Related Experiment Video
Updated: May 16, 2026
Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors
Jessica A Walsh1, Kristina Callis Duffin, Julia Crim
1George E. Wahlen Veteran Affairs Medical Center, University of Utah, Division of Rheumatology, Salt Lake City, UT, USA. jessica.walsh@hsc.utah.edu
Study Objectives:
Sleep disturbances, including obstructive sleep apnea (OSA), commonly limit function and quality of life in people with spondyloarthritis (SpA). Systemic inflammation has been implicated in the pathophysiology of both OSA and SpA, and suppression of inflammation with tumor necrosis factor α (TNF) inhibitors may decrease OSA severity. In this study, we compared the frequency of OSA in patients receiving and not receiving TNF-inhibitor therapy.
Methods:
Data were collected from 63 consecutively screened veterans with SpA. Participant interviews, examinations, chart reviews, and referrals to the Salt Lake City Veteran Affairs (SLCVA) Sleep Center were used to obtain demographic data, comorbidities, SpA features, therapy data, and sleep study outcomes.
Results:
OSA occurred in 76% of SpA patients. OSA was less common in patients receiving TNF-inhibitor therapy (57%), compared to patients not receiving TNF-inhibitor therapy (91%) (p = 0.01).
Conclusions:
OSA is underrecognized in veterans with SpA, and TNF-inhibition was associated with a lower frequency of OSA.
Related Concept Videos
01:21Sleep Apnea
The condition is more prevalent among...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF